Cardiac Safety Data for Casopitant, a Neurokinin-1 Receptor Antagonist, Given with Anthracycline

被引：0
|
作者：
Ewer, M. S.
Grunberg, S.
Ranganathan, S.
Lane, S.
Russo, M.
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Univ Vermont, Vermont Canc Ctr, Burlington, VT USA
来源：
CANCER RESEARCH | 2009年 / 69卷 / 24期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：576S / 576S
页数：1
相关论文
共 50 条
  • [1] Casopitant, a neurokinin-1 receptor antagonist with anti-emetic and antinausea activities
    Navari, Rudolph M.
    CURRENT OPINION IN INVESTIGATIONAL DRUGS, 2008, 9 (07) : 774 - 785
  • [2] Ketoconazole and Rifampin Significantly Affect the Pharmacokinetics, But Not the Safety or QTc Interval, of Casopitant, a Neurokinin-1 Receptor Antagonist
    Johnson, Brendan M.
    Adams, Laurel M.
    Zhang, Ke
    Gainer, Shelby D.
    Kirby, Lyndon C.
    Blum, Robert A.
    Apseloff, Glen
    Morrison, Royce A.
    Schutz, Ralph A.
    Lebowitz, Peter F.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 50 (08): : 951 - 959
  • [3] Pharmacokinetics and brain penetration of casopitant, a potent and selective neurokinin-1 receptor antagonist, in the ferret
    Minthorn, Elisabeth
    Mencken, Thomas
    King, Andrew G.
    Shu, Art
    Rominger, David
    Gontarek, Richard R.
    Han, Chao
    Bambal, Ramesh
    Davis, Charles B.
    DRUG METABOLISM AND DISPOSITION, 2008, 36 (09) : 1846 - 1852
  • [4] Metabolic Disposition of Casopitant, a Potent Neurokinin-1 Receptor Antagonist, in Mice, Rats, and Dogs
    Miraglia, Lidia
    Pagliarusco, Sabrina
    Bordini, Ellenia
    Martinucci, Silvia
    Pellegatti, Mario
    DRUG METABOLISM AND DISPOSITION, 2010, 38 (10) : 1876 - 1891
  • [5] Effect of casopitant, a novel neurokinin-1 receptor antagonist, on the pharmacokinetics (PK) of the oral contraceptive pill (OCP)
    Adams, Laurel M.
    Zamuner, Stefano
    Fina, Paolo
    Peroni, Michela
    Johnson, Brendan M.
    Fernandes, Sofia
    MOLECULAR CANCER THERAPEUTICS, 2009, 8 (12)
  • [6] Safety of neurokinin-1 receptor antagonists
    Munoz, Miguel
    Covenas, Rafael
    EXPERT OPINION ON DRUG SAFETY, 2013, 12 (05) : 673 - 685
  • [7] A SELECTIVE AND EXTREMELY POTENT ANTAGONIST OF THE NEUROKININ-1 RECEPTOR
    SAKURADA, T
    MANOME, Y
    TANNO, K
    SAKURADA, S
    OHBA, M
    KISARA, K
    TERENIUS, L
    REGULATORY PEPTIDES, 1993, 46 (1-2) : 326 - 328
  • [8] A SELECTIVE AND EXTREMELY POTENT ANTAGONIST OF THE NEUROKININ-1 RECEPTOR
    SAKURADA, T
    MANOME, Y
    TANNO, K
    SAKURADA, S
    KISARA, K
    OHBA, M
    TERENIUS, L
    BRAIN RESEARCH, 1992, 593 (02) : 319 - 322
  • [9] A SELECTIVE AND EXTREMELY POTENT ANTAGONIST OF THE NEUROKININ-1 RECEPTOR
    SAKURADA, T
    MANOME, Y
    TANNO, K
    SAKURADA, S
    OHBA, M
    KISARA, K
    TERENIUS, L
    REGULATORY PEPTIDES, 1992, : S139 - S139
  • [10] Efficacy of Vestipitant, A Neurokinin-1 Receptor Antagonist, in Primary Insomnia
    Ratti, Emiliangelo
    Carpenter, David J.
    Zamuner, Stefano
    Fernandes, Sofia
    Squassante, Lisa
    Danker-Hopfe, Heidi
    Archer, Graeme
    Robertson, Jonathan
    Alexander, Robert
    Trist, David G.
    Merlo-Pich, Emilio
    SLEEP, 2013, 36 (12): : 1823 - 1830
12345